Maxigen Biotech Market Cap

Maxigen Biotech has a market cap or net worth of 3.95 billion as of July 9, 2025. Its market cap has decreased by -2.94% in one year.

Market Cap

3.95B

Enterprise Value

3.24B

Revenue

730.77M

Ranking

n/a

PE Ratio

19.00

Stock Price

44.00

Market Cap Chart

Since December 23, 2013, Maxigen Biotech's market cap has increased from 3.53B to 3.95B, an increase of 11.93%. That is a compound annual growth rate of 0.98%.

Market Cap History

Date	Market Cap	% Change
Jul 9, 2025	3.95B	-9.59%
Dec 31, 2024	4.36B	1.40%
Dec 29, 2023	4.30B	6.65%
Dec 30, 2022	4.04B	0.99%
Dec 30, 2021	4.00B	151.22%
Dec 31, 2020	1.59B	-9.31%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Caliway Biopharmaceuticals	205.51B
PharmaEssentia	180.30B
Bora Pharmaceuticals Co., LTD.	81.72B
Lotus Pharmaceutical	57.98B
Polaris Group	29.89B
Oneness Biotech	28.84B
Center Laboratories	26.25B
TaiMed Biologics	24.55B

Market Cap Rankings